Cala Secures FDA Clearance for Next‑Gen TAPS Wearable Targeting Tremor in ET and Parkinson's
Cala Health announced FDA clearance of its next‑generation kIQ Plus wearable neurostimulation system for essential tremor and Parkinson's disease. The device introduces new therapy modes and adaptive calibration, and will be showcased with clinical data at the American Academy of Neurology meeting in Chicago.
AI-Driven CRISPR‑GPT Enables Fully Autonomous Lab Experiments
A junior researcher walks up to a CRISPR experiment they've never run before. An AI agent has already decomposed the workflow, selected the guide RNAs, anticipated failure modes, and drafted the protocol. They run it successfully on their first attempt. That's not...
Obesity Treatment Firm Kailera Upsizes IPO to Raise $625 Million
Kailera Therapeutics Inc., a clinical‑stage biotech specializing in obesity treatments, announced an upsized initial public offering. The company sold roughly 39 million shares at $16 each, raising $625 million, the largest U.S. biotech listing since 2021. The offering was priced at the...
From Lockdown to the Lab: Researcher Develops 'Decoy Molecule' To Slow Down Coronavirus
During the COVID‑19 lockdown, Ph.D. candidate Koen Rijpkema engineered decoy molecules that bind tightly to the coronavirus Mac1 enzyme, which normally dampens immune signaling. By mimicking the enzyme’s natural substrate, the decoys keep Mac1 occupied, allowing the immune system to detect...
Choose the Right Design, Not One‑Size Truth
n=1 is can work for cancer and infectious disease, but often you need a clinical trial. We need to always be asking what the best tool is to get to truth. Don't assume that one experimental design is always correct. And don't...
Menstrual Cycle Reshapes Nearly 200 Blood Proteins, Offering a Broader View of Women's Health
A team at Aarhus University mapped the blood proteome across the menstrual cycle, identifying nearly 200 proteins that fluctuate systematically. The study, published in Nature Medicine, reveals that these changes affect immune, hormonal, and metabolic pathways far more than previously...
Funding the Future of European Biotech
In a BioSpace Insights “Denatured” podcast, host Jennifer C. Smith‑Parker talks with Edoardo Negroni of AurorA‑TT and Naveed Siddiqi of Novo Holdings about Europe’s world‑class biotech science and the venture ecosystem needed to commercialize it. The guests argue that Europe’s research...
High-Precision Human Immune Aging Clock Identifies RUNX1 as Key Target for T Cell Senescence
Researchers from the Chinese Academy of Sciences unveiled a high‑precision Human Immune Aging Clock (HIAC) that leverages single‑cell multi‑omics to predict immune age with a 5.66‑year mean absolute error. The clock identifies T cells as the most sensitive cellular indicator...
Weight Loss, Obesity Drugs Bring Potential New MASLD, MASH Treatment Strategies
A new review in *Diabetes, Obesity and Metabolism* shows that GLP‑1, GIP and glucagon‑based drugs, originally approved for obesity and diabetes, also improve liver outcomes in metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form MASH. A recent meta‑analysis...
They Froze a Brain to −196°C. Then Brought It ‘Back to Life’ in a Groundbreaking New Study.
Researchers at the University Hospital Erlangen demonstrated that mouse hippocampal tissue can survive vitrification at –196 °C and resume normal neuronal activity after rewarming. The study, published in PNAS, showed structural integrity and functional synaptic signaling in brain slices, with modest...
Designing Implants that Don’t Scar the Brain
A new study systematically compared stiff silicon electrodes with flexible polyimide probes for intracortical neural implants. The researchers found that material choice dominates tissue response: polyimide probes trigger far less scarring and inflammation than silicon, while probe thickness or wireless...
A Single Measurement Sorts Chiral Molecules by Type, Handedness, and Ratio
Researchers have unveiled a terahertz circular dichroism platform that uses an achiral gradient metasurface to identify chiral biomolecules, their handedness, and mixing ratios in a single broadband scan. The metasurface reflects terahertz light from 0.5 to 1.8 THz without adding background...
Kennedy: 90% Of FDA Reviewers Are Using AI For Faster Drug Approvals
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. told the House Ways & Means Committee that more than 90% of FDA reviewers are now using artificial‑intelligence tools to speed drug approvals. The AI applications are also being rolled...
Vitamin C Cuts Iron‑Related Aging Markers in Monkeys
Researchers have demonstrated that high‑dose vitamin C supplementation lowers iron‑induced oxidative damage and senescence markers in aged cynomolgus monkeys. The findings point to a nutraceutical strategy for slowing cellular aging and have sparked interest across the biohacking community.
Biogen's Stock Slumps as Biosimilars Hit MS Sales and Alzheimer Setbacks Loom
Biogen (BIIB) saw its stock slip after reporting modest revenue growth, heightened biosimilar competition in multiple sclerosis, and lingering commercial challenges for its Alzheimer’s drug Leqembi. The biotech’s 2025 revenue rose only 2% to $9.9 billion while adjusted EPS fell 7%,...
Spotlight On: Biosimilar Litigations - April 2026
The April 2026 Spotlight On: Biosimilar Litigations memo outlines which patent disputes are tracked in the sector. It clarifies that lawsuits between biosimilar applicants or manufacturers and reference‑product sponsors are included, while conflicts solely among reference sponsors or non‑practicing entities are...
UK Says It Has Hit Target on Commercial Trial Set-Up Times
The UK’s National Institute for Health and Care Research (NIHR) reported that average clinical‑trial set‑up time fell to 122 days in the six months to March, beating its 150‑day target set for March 2026. The reduction follows a suite of reforms,...
Nanoz Rolls Out AI‑powered 2 Mm Nanosensors for Health and Environmental Monitoring
Nanoz, a French deep‑tech company, announced the industrial launch of AI‑enabled nanosensors no larger than 2 mm. The devices combine metal‑oxide semiconductor gas detection with machine‑learning algorithms to identify disease biomarkers, cabin‑air hazards and urban pollutants, opening new markets in healthcare,...
Researchers Encode Full Hepatitis D Genome on IBM Quantum System One
Scientists from the Wellcome Sanger Institute, Oxford, Cambridge, Melbourne and Kyiv Academic University have loaded a complete Hepatitis D virus genome onto IBM Quantum System One’s 156‑qubit Heron processor. The milestone, achieved under the Wellcome Leap‑funded Q4Bio Challenge, demonstrates that...
MeiraGTx Reacquires Gene Therapy Candidate Bota-Vec for X‑Linked Retinitis Pigmentosa
MeiraGTx Holdings plc announced it has signed an asset purchase agreement with Johnson & Johnson to reacquire botaretigene sparoparvovec (bota-vec), its AAV‑RPGR gene‑therapy for X‑linked retinitis pigmentosa (XLRP). The company says the deal positions it to file Biologics License Applications...
The Category 2 Peptide Unwind: How a Rogan Appearance, 14 Withdrawn Nominations & a July PCAC Docket Will Reprice the...
Kennedy’s appearance on The Joe Rogan Experience announced that roughly fourteen peptides could be re‑classified from FDA Category 2 back to Category 1, but no Federal Register rule has been issued yet. The announcement highlights a procedural path where nominators withdraw nominations,...
Staging, ctDNA, and the Art of Personalizing Metastatic Breast Cancer Therapy: Hayley Knollman, MD
Hayley M. Knollman, MD, highlighted how estrogen‑receptor‑positive metastatic breast cancer still relies on conventional staging—blood work, imaging, and tissue biopsies—while emerging HER2‑low categories gain relevance only after disease spreads. She noted that circulating tumor DNA (ctDNA) and broad genomic panels are now...
![[April 2026] FDA Form 483 Response Guidance, Weight Loss Device Framework + AI-Driven Device Warning Letter](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://substackcdn.com/image/fetch/$s_!CHiL!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F59dae4d3-b9e4-442b-8b97-0a78fab4dc99_582x582.png)
[April 2026] FDA Form 483 Response Guidance, Weight Loss Device Framework + AI-Driven Device Warning Letter
The FDA released three pivotal documents in April 2026: a finalized guidance on responding to Form 483 observations, a structured benefit‑risk framework for weight‑loss devices, and a warning letter to an autonomous insulin‑delivery system. The Form 483 guidance offers the...
OpenAI Debuts GPT-Rosalind, a New Limited Access Model for Life Sciences, and Broader Codex Plugin on Github
OpenAI unveiled GPT‑Rosalind, a domain‑specific reasoning model built to accelerate life‑science research, alongside a Codex plugin that links the model to over 50 public multi‑omics databases. The model demonstrated top‑tier performance on benchmarks such as BixBench and LABBench2, surpassing GPT‑5.4...
Flawed Study Groups Failed and Successful Alzheimer Drugs Together
This new analysis of Alzheimer's drugs is such a good example of why we can't make any headway as a society. There is probably a good debate to be had on whether the risks and costs of the two approved beta...
For Regrowing Human Limbs, This Salamander Gene Could Hold the Key
Scientists identified SP6 and SP8 as conserved genes that drive limb regeneration in axolotls, zebrafish and mice, and demonstrated that a viral gene‑therapy delivering FGF8 can partially rescue digit regrowth in mice lacking these genes. The work, published in PNAS,...
FDA Signals Potential Expansion of Testosterone Therapy to Treat Low Libido in Idiopathic Hypogonadism
The FDA announced it will entertain supplemental new drug applications to add low libido in men with idiopathic hypogonadism as an approved indication for existing testosterone replacement therapy (TRT) products. The move follows a December 2025 expert panel review of...
Clinical Trial of a Prion Disease Drug Candidate Begins Enrolling Participants
Broad Institute and UMass Chan have launched the first human trial of a prion disease therapy, a divalent small interfering RNA designed to silence the prion protein gene. The phase 1 PRiSM study will enroll 15 symptomatic patients to assess...
Pharmaceutical Executive Daily: Eli Lilly Releases Updated Safety Data for Foundayo
Eli Lilly has released topline safety results from its Phase III Achieve‑4 trial for Foundayo, addressing FDA‑requested evidence on cardiovascular, liver and gastric safety. The FDA’s post‑approval letter, issued on the day of approval, demanded trial data rather than observational studies. Concurrently,...
RSV Vaccines Work to Prevent Hospitalization
Recent clinical data show that newly approved respiratory syncytial virus (RSV) vaccines dramatically cut hospital admissions. In infants, the vaccine lowered hospitalization risk by roughly 70%, while older adults experienced a 50% reduction in severe cases. The FDA has accelerated...
Roche to Start Phase III Trial to Broaden Access to Elevidys in Duchenne Muscular Dystrophy
Roche announced a global, pivotal Phase III trial of Elevidys, its gene‑therapy for Duchenne muscular dystrophy, targeting roughly 100 early‑ambulatory boys. The 72‑week, placebo‑controlled study will assess change in time‑to‑rise‑from‑floor velocity as the primary efficacy endpoint. Results are intended to bolster...
Study Data Technical Conformance Guide - Technical Specifications Document
The FDA has issued the final Study Data Technical Conformance Guide (Docket FDA-2014-D-0092), outlining technical specifications for electronic study data submissions. The guidance clarifies the agency’s expectations but remains non‑binding, allowing sponsors to use alternative approaches that meet regulatory requirements....
Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee...
The FDA announced a public meeting on June 23, 2026 to discuss financial transparency and efficiency of the Prescription Drug User Fee Act (PDUFA VII), Biosimilar User Fee Act (BsUFA III) and Generic Drug User Fee Act (GDUFA III). The session will present five‑year financial...
Genome Sequencing Solves Rare Disease Mysteries
A Karolinska Institute study of more than 15,000 patients used whole‑genome sequencing to pinpoint a genetic cause in 22.6% of cases, marking one of the largest clinical genome‑sequencing efforts to date. The program uncovered over 4,400 disease‑causing variants across 1,570...
Batch of Anti-Anxiety Drug Xanax Recalled, F.D.A. Says
The FDA announced a recall of a single batch of Xanax XR, the extended‑release formulation of the popular anti‑anxiety medication. Viatris, the drug’s distributor, is pulling 51 bottles of 3 mg tablets because they may not dissolve properly, potentially altering drug...
From Static Snapshots to Dynamic Protein Modeling
AlphaFold solved protein structure prediction. That's a snapshot. But biology isn't static. Proteins flex, shift, and interact across time. Drug targets have multiple conformations. Cells don't act alone. The next hard problem is capturing that motion, and building models that reflect...
Mitochondrial Transplantation Reverses Cell Degeneration
In terms of my top bets for rejuvenation-based therapies, mitochondrial transplanation has entered the chat Cell-type-targeted mitochondrial transplantation rescues cell degeneration https://t.co/izvDaRk7kz
Toward Equitable Access to Cell and Gene Therapies: Rethinking Co-Payments
Cell and gene therapies now command one‑time price tags exceeding $3 million, creating affordability challenges for the U.S. health‑care system. While patient cost sharing represents a tiny slice of total spending, deductibles and coinsurance can still impose thousands of dollars in...
Cellular Stress Drives Stem Cell Aging, Revealing Therapy Targets
Beyond Cell Death: The Hidden Drivers of Stem Cell Aging “The findings shed light on how cellular stress shapes stem cell aging and highlight potential pathways for developing therapies to counter age-related decline...” https://t.co/hBUchsNtQ4 https://t.co/6HyOSZZ6ZS
Over 3,000 Brain Genes Show Sex‑Specific Expression
Sex-specific gene expression of the human brain, for >3,000 genes (of our ~20,000 total) @ScienceMagazine https://t.co/jQUFgARmuA https://t.co/0qNr9XPnP4
Scientists Identify Picalm Protein Activated by Exercise and Fasting
Researchers from Germany's Institute of Human Nutrition and the German Center for Diabetes Research reported that the protein Picalm surges in skeletal muscle after exercise and intermittent fasting, driving the formation of new muscle fibers. The finding opens a potential...
P21⁺TREM2⁺ Macrophages Drive Inflammaging and Liver Disease
Delighted to be part of this study identifying p21⁺TREM2⁺ senescent macrophages as drivers of inflammaging and metabolic liver disease. A fantastic collaboration led by @ACovarrubiasPhD 👏
OpenAI Unveils GPT‑Rosalind for Pharma Drug Discovery
I truly believe OpenAI is hoping to drive a ton of revenue based on what it can do with health/medical -> OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers...
RFK Jr. Defends FDA Chief Amid Industry Backlash
RFK Jr. defends FDA, Makary following Republican questions - also defends the $REPL CRL: "Marty made the correct decision to not approve that drug. But everybody goes after him because the industry is so powerful." https://t.co/CuEeNFCYpp
High‑Resolution TORC2 Structure Opens Path to Age‑Related Therapies
Activating TORC2 holds potential in medicine for treating age-related memory & hearing loss. New study out today @MolecularCell reveals the structure of TORC2 in highest-ever resolution - which is good news for drug developers & all of us who age...
Drug Discovery Expands Beyond AI to New Frontiers
The marked expansion of paths and methods for new drug development including and beyond AI @Joseph_C_Wu @james_y_zou @WuXuekun @ScienceMagazine https://t.co/hTJ4Rt181n https://t.co/H3U5BNR1ER
1q22 Gain Predicts Poor Prognosis in Myeloma
Prognostic significance of acquired 1q22 gain in multiple myeloma [Oct 28, 2021] Hadiyah Y Audil et al. @myelomaMD Am J Hematol https://t.co/qUKCUdnZPH #mmsm #PrecisionMedicine #oncopath HT @EagleMyeloma https://t.co/vd0BVZ6bRq
1q Abnormalities Define Distinct Proteomic Landscape in Myeloma
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myeloma [Apr 14, 2026] Mangalaparthi et al. @Nature_NPJ https://t.co/XTcJZIGFh6 #mmsm #PrecisionMedicine HT @Myeloma_Doc https://t.co/XyrxJ29elO
DNA Circles in Cancers Show Accelerated Epigenetic Aging
30 years ago, we discovered circular DNA molecules 1. pinch off yeast chromosomes 2. multiply 3. sequester epigenetic regulators (eg sirtuins) 5. cause aging New review today @CellCellPress about DNA circles in human cancers - which are epigenetically older than normal cells https://t.co/VlkBWCFnPi
Scientists Propose Abandoning GLP‑1 as Obesity Target
Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target https://t.co/ADzYb2Zqal via @statnews